High-dose melphalan and autologous stem cell transplantation after VAD 
chemotherapy for systemic light chain (AL) amyloidosis

Perz, J. B.; Schoenland, S.; Hundemer, M.; Linke, R. P.; Ho, A. D.; Goldschmidt, H.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

High-dose melphalan and autologous stem cell transplantation after VAD chemotherapy for systemic light chain (AL) amyloidosis

MPS-Authors

/persons/resource/persons78324

Linke, R. P.
Huber, Robert / Structure Research, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Perz, J. B., Schoenland, S., Hundemer, M., Linke, R. P., Ho, A. D., & Goldschmidt, H. (2004). High-dose melphalan and autologous stem cell transplantation after VAD chemotherapy for systemic light chain (AL) amyloidosis. Bone Marrow Transplantation, 33(Suppl. Suppl. 1), S159-S159.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-69BE-0

Abstract

There is no abstract available